BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism
Xiao-Hua Li,Jia-Yin Xu,Xue Wang,Li-Juan Liao,Liang Huang,Yan-Qiang Huang,Zeng-Feng Zhang
DOI: https://doi.org/10.3748/wjg.v29.i18.2818
IF: 5.374
2023-05-14
World Journal of Gastroenterology
Abstract:BACKGROUND: <i>Helicobacter pylori</i> (<i>H. pylori</i>) is the main pathogen that causes a variety of upper digestive diseases. The drug resistance rate of <i>H. pylori</i> is increasingly higher, and the eradication rate is increasingly lower. The antimicrobial resistance of <i>H. pylori</i> is an urgent global problem. It has been confirmed that Banxia Xiexin decoction (BXXXT) demonstrates the effects of treating gastrointestinal diseases, inhibiting <i>H. pylori</i> and protecting gastric mucosa. The purpose of the present study is to further explore the therapeutic effects of BXXXT on drug-resistant <i>H. pylori</i>.AIM: To confirm that BXXXT demonstrates therapeutical effects <i>in vivo</i> and <i>in vitro</i> on gastritis mice with drug-resistant <i>H. pylori</i> and explain its mechanism to provide an experimental basis for promoting the application of BXXXT.METHODS: The aqueous extract of BXXXT was gained by water decocting method. The inhibitory effect of the aqueous extract on <i>H. pylori</i> was detected by dilution <i>in vitro</i>; drug-resistant <i>H. pylori</i> cells were used to build an acute gastritis model <i>in vivo</i>. Thereafter, the model mice were treated with the aqueous extract of BXXXT. The amount of <i>H. pylori</i> colonization, the repair of gastric mucosal damage, changes of inflammatory factors, apoptosis, <i>etc</i>., were assessed. In terms of mechanism exploration, the main medicinal compositions of BXXXT aqueous extract and the synergistic bacteriostatic effects they had demonstrated were analyzed using mass spectrometry; the immune function of peripheral blood cells such as CD3<sup>+</sup> T and CD4<sup>+</sup> T of mice with gastritis before and after treatment with BXXXT aqueous extract was detected using a flow cytometry; the <i>H. pylori</i> transcriptome and proteome after treatment with BXXXT aqueous extract were detected. Differently expressed genes were screened and verification was performed thereon with knockout expression.RESULTS: The minimum inhibitory concentration of BXXXT aqueous extract against <i>H. pylori</i> was 256-512 μg/mL. A dose of 28 mg/kg BXXXT aqueous extract treatment produced better therapeutical effects than the standard triple therapy did; the BXXXT aqueous extract have at least 11 ingredients inhibiting <i>H. pylori</i>, including berberine, quercetin, baicalin, luteolin, gallic acid, rosmarinic acid, aloe emodin, <i>etc</i>., of which berberine, aloe emodin, luteolin and gallic acid have a synergistic effect; BXXXT aqueous extract was found to stimulate the expressions of CD3<sup>+</sup> T and CD4<sup>+</sup> T and increase the number of CD4<sup>+</sup> T/CD8<sup>+</sup> T in gastritis mice; the detection of transcriptome and proteome, quantitative polymerase chain reaction, Western blotting and knockout verification revealed that the main targets of BXXXT aqueous extract are <i>CFAs</i> related to urea enzymes, and <i>CagA</i>, <i>VacA</i>, <i>etc</i>.CONCLUSION: BXXXT aqueous extract could demonstrate good therapeutic effects on drug-resistance <i>H. pylori in vitro</i> and <i>in vivo</i> and its mechanism comes down to the synergistic or additional antibacterial effects of berberine, emodin and luteolin, the main components of the extract; the extract could activate the immune function and enhance bactericidal effects; BXXXT aqueous extract, with main targets of BXXXT aqueous extract related to urease, virulence factors, <i>etc</i>., could reduce the urease and virulence of <i>H. pylori</i>, weaken its colonization, and reduce its inflammatory damage to the gastric mucosa.
gastroenterology & hepatology